Robert Edward Kelly Net Worth

The estimated Net Worth of Robert Edward Kelly is at least $2.91 Миллион dollars as of 3 May 2021. Robert Kelly owns over 2,053 units of Zoetis Inc stock worth over $1,576,917 and over the last 5 years Robert sold ZTS stock worth over $1,335,260.

Robert Kelly ZTS stock SEC Form 4 insiders trading

Robert has made over 6 trades of the Zoetis Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Robert sold 2,053 units of ZTS stock worth $358,659 on 3 May 2021.

The largest trade Robert's ever made was exercising 2,909 units of Zoetis Inc stock on 14 February 2020 worth over $552,681. On average, Robert trades about 788 units every 26 days since 2020. As of 3 May 2021 Robert still owns at least 8,300 units of Zoetis Inc stock.

You can see the complete history of Robert Kelly stock trades at the bottom of the page.

What's Robert Kelly's mailing address?

Robert's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.

Insiders trading at Zoetis Inc

Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio и Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.

What does Zoetis Inc do?

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.

Complete history of Robert Kelly stock trades at Zoetis Inc

Zoetis Inc executives and stock owners

Zoetis Inc executives and other stock owners filed with the SEC include:

• Glenn David,
  Chief Financial Officer, Executive Vice President
• Kristin Peck,
  Chief Executive Officer, Director
• Catherine Knupp,
  Executive Vice President, President - Research and Development
• Kristin C. Peck,
  CEO & Director
• Wafaa Mamilli,
  Exec. VP and Chief Information & Digital Officer
• Roman Trawicki,
  Exec. VP and Pres of Global Manufacturing & Supply
• Glenn C. David,
  Exec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance
• Michael McCallister,
  Non-Executive Independent Chairman of the Board
• Robert Scully,
  Independent Director
• Gregory Norden,
  Independent Director
• Paul Bisaro,
  Independent Director
• William Steere,
  Independent Director
• Linda Rhodes,
  Independent Director
• Willie Reed,
  Independent Director
• Louise Parent,
  Independent Director
• Sanjay Khosla,
  Independent Director
• Frank D'Amelio,
  Independent Director
• Roman Trawicki,
  Executive Vice President, President - Global Manufacturing and Supply
• Heidi Chen,
  Executive Vice President, General Counsel, Corporate Secretary
• Roxanne Lagano,
  Chief Human Resource Officer, Executive Vice President and Global Operations
• Heidi C. Chen,
  Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics
• Roxanne Lagano,
  Exec. VP and Chief HR Officer & Global Operations
• Wetteny N. Joseph,
  Exec. VP & CFO
• Timothy J. Bettington,
  Exec. VP and Pres of U.S. Operations & Global Customer Experience
• William Price,
  VP & Chief Communications Officer
• Steven Frank,
  VP of Investor Relations
• Gavin Hattersley,
  Director
• Robert Edward Kelly,
  Executive Vice President
• Alejandro Bernal,
  Executive Vice President
• Juan Ramon Alaix,
  Director
• Clinton A. Jr. Lewis,
  Executive Vice President
• Sherry N Pudloski,
  Executive Vice President
• Robert J Polzer,
  Executive Vice President
• Amy W Schulman,
  Director
• Sandra J. Beaty,
  Executive Vice President
• Joyce J. Lee,
  Executive Vice President
• Douglas E. Giordano,
  Director
• William F Doyle,
  
• Inc Pfizer,
  Director
• Square Capital Management, ...,
  
• Stefan Weiskopf,
  Executive Vice President
• Richard A. Passov,
  EVP, Chief Financial Officer
• Paul Herendeen,
  Exec. V.P. and CFO
• Charles H Hill,
  Director
• Geno J Germano,
  Director
• Andrew Fenton,
  Executive Vice President
• James Michael Mc Farland,
  Executive Vice President
• Wafaa Mamilli,
  Executive Vice President
• Timothy J Bettington,
  Executive Vice President
• Antoinette Renee Leatherberry,
  Director
• Astorga Jeannette Ferran,
  Executive Vice President
• Abhay U Nayak,
  Executive Vice President
• Wetteny Joseph,
  Chief Financial Officer
• Rimma Driscoll,
  Executive Vice President
• Vanessa Broadhurst,
  Director
• Jamie Brannan,
  Executive Vice President
• Nicholas Ashton,
  Executive Vice President
• Soria Ester Banque,
  Executive Vice President